Tenax Therapeutics (TENX) Interest & Investment Income (2022 - 2026)
Tenax Therapeutics (TENX) reported Interest & Investment Income of $861000.0 for Q1 2026, down 7.42% on a YoY basis from $930000.0 in Q1 2025, and down 6.21% sequentially from $918000.0 in Q4 2025.
Tenax Therapeutics (TENX) Interest & Investment Income (2022 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 5 years of Interest & Investment Income data on file, last reported at $861000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 7.42% year-over-year to $861000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 37.56% YoY), and the FY2025 full-year result was $3.8 million, up 99.53% from the prior year.
- Interest & Investment Income slipped to $861000.0 in Q1 2026, from $918000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.0 million in Q4 2024 to a low of -$150741.0 in Q3 2023.
- A 5-year average of $571850.6 and a median of $850877.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 221898.41% in 2023 and fell 25.64% in 2024, its largest moves.
- Tracing TENX's Interest & Investment Income over 5 years: stood at $63.0 in 2022, then soared by 1350498.41% to $850877.0 in 2023, then increased by 20.7% to $1.0 million in 2024, then retreated by 10.61% to $918000.0 in 2025, then slipped by 6.21% to $861000.0 in 2026.
- Business Quant data shows TENX's Interest & Investment Income at $861000.0 in Q1 2026, $918000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Tenax Therapeutics | 729.95 Mn | 729.95 Mn | - | 861,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 918,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 954,000.00 |
| Mar 31, 2025 | 930,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 665,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 118,000.00 |
| Dec 31, 2023 | 850,877.00 |
| Sep 30, 2023 | -150,741.00 |
| Jun 30, 2023 | 139,859.00 |
| Jun 30, 2022 | 63.00 |